Concentrix 8-K: No New Officer Changes or Comp Arrangements

TL;DR

**Concentrix 8-K shows no new executive changes or compensation, signaling stability.**

AI Summary

Concentrix Corporation filed an 8-K on January 5, 2024, reporting no new material events regarding departures or appointments of officers or directors, nor any new compensatory arrangements. The filing simply confirms the company's current status and its common stock trading on The Nasdaq Stock Market LLC under the symbol CNXC. This matters to investors because it indicates a period of stability with no immediate changes in leadership or executive compensation that could impact the company's strategic direction or financial health.

Why It Matters

This filing indicates business as usual for Concentrix, with no immediate changes in executive leadership or compensation that could signal a shift in company strategy or financial outlook. Investors can interpret this as a period of operational stability.

Risk Assessment

Risk Level: low — The filing reports no significant changes, which generally indicates a low immediate risk to investors from the reported events.

Analyst Insight

A smart investor would note the lack of significant news as a sign of stability, but would look to other filings (like 10-K or 10-Q) for more substantive operational or financial updates, as this 8-K is primarily administrative.

Key Numbers

• $0.0001 — par value per share (par value of Concentrix Common Stock)

Key Players & Entities

• Concentrix Corporation (company) — the registrant filing the 8-K
• The Nasdaq Stock Market LLC (company) — exchange where Concentrix Common Stock is registered
• CNXC (company) — trading symbol for Concentrix Common Stock
• January 4, 2024 (date) — date of earliest event reported
• January 5, 2024 (date) — date the 8-K was filed
• $0.0001 (dollar_amount) — par value per share of Common Stock

Forward-Looking Statements

• Concentrix will maintain its current executive leadership team. (Concentrix Corporation) — high confidence, target: Q1 2024
• No significant changes to executive compensatory arrangements will be announced in the near term. (Concentrix Corporation) — high confidence, target: Q1 2024

FAQ

Key Financial Figures

• $0.0001 — ich registered Common Stock, par value $0.0001 per share CNXC The Nasdaq Stock Market

Filing Documents

• cnxc-20240104.htm (8-K) — 24KB
• 0001803599-24-000004.txt ( ) — 149KB
• cnxc-20240104.xsd (EX-101.SCH) — 2KB
• cnxc-20240104_lab.xml (EX-101.LAB) — 24KB
• cnxc-20240104_pre.xml (EX-101.PRE) — 13KB
• cnxc-20240104_htm.xml (XML) — 3KB

From the Filing

cnxc-20240104 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 4, 2024 CONCENTRIX CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-39494 27-1605762 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) 39899 Balentine Drive , Suite 235 , Newark , California 94538 (Address of principal executive offices) (Zip Code) ( 800 ) 747-0583 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.0001 per share CNXC The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 4, 2024, the Board of Directors of Concentrix Corporation (the "Company") appointed Craig Gibson to the role of Executive Vice President, Global Sales and Account Management, effective immediately. Mr. Gibson joined the Company in connection with the Company's combination with Webhelp and previously served as the Chief Growth Officer of Webhelp. Mr. Gibson was appointed to succeed Rick Rosso as part of the Company's executive officer succession planning. Mr. Rosso will continue with the Company and transition into a non-executive officer leadership role with the Company for an unspecified period of time prior to his retirement. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 5, 2024 CONCENTRIX CORPORATION By: /s/ Jane C. Fogarty Jane C. Fogarty Executive Vice President, Legal

View Full Filing

View this 8-K filing on SEC EDGAR